Literature DB >> 17904964

Fetal cord blood mononuclear cells that are collected at term from HIV-1 infected women harbor transcriptionally active integrated proviral DNA.

Jane E Ellis1, Gregory A Hair, Michael K Lindsay, Aftab A Ansari, J Bruce Sundstrom.   

Abstract

OBJECTIVE: The purpose of this study was to determine levels of intrauterine infection and transcriptional activity in cord blood mononuclear cells that were collected at term from fetuses who were born to women who were infected with human immunodeficiency virus (HIV) and who received highly active antiretroviral therapy (HAART). STUDY
DESIGN: RNA and DNA were isolated from maternal placental tissues and fetal cord blood specimens that were obtained at term from pregnant women who were infected with HIV and who received HAART. Levels of integrated HIV provirus and messenger RNA transcripts were determined by real-time polymerase chain reaction.
RESULTS: Detectable levels of transcriptionally active integrated provirus were present in approximately 27% of cord blood samples (n = 22) that were collected from fetuses who born to HIV-positive mothers who received HAART. Levels of HIV-p24 antigen in cultures that were detected in randomly selected cord blood samples confirmed the presence of inducible infectious virus.
CONCLUSION: These findings suggest that some fetuses from HIV-infected mothers who receive HAART and who may be HIV-negative infants after delivery can harbor circulating leukocytes that are infected productively by intrauterine transmission of HIV.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17904964      PMCID: PMC2099629          DOI: 10.1016/j.ajog.2007.06.043

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  23 in total

1.  Understanding the timing of HIV transmission from mother to infant.

Authors:  A P Kourtis; M Bulterys; S R Nesheim; F K Lee
Journal:  JAMA       Date:  2001-02-14       Impact factor: 56.272

2.  U.S. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States.

Authors:  Lynne M Mofenson
Journal:  MMWR Recomm Rep       Date:  2002-11-22

3.  Pseudotypes of vesicular stomatitis virus-bearing envelope antigens of certain HIV-1 strains permissively infect human syncytiotrophoblasts cultured in vitro: implications for in vivo infection of syncytiotrophoblasts by cell-free HIV-1.

Authors:  A Bácsi; P Ebbesen; J Szabó; Z Beck; I Andirkó; E Csoma; F D Tóth
Journal:  J Med Virol       Date:  2001-08       Impact factor: 2.327

4.  Human immunodeficiency virus infection is a risk factor for adverse perinatal outcome.

Authors:  Jane Ellis; Harriet Williams; William Graves; Michael K Lindsay
Journal:  Am J Obstet Gynecol       Date:  2002-05       Impact factor: 8.661

5.  Human tissue mast cells are an inducible reservoir of persistent HIV infection.

Authors:  J Bruce Sundstrom; Jane E Ellis; Gregory A Hair; Arnold S Kirshenbaum; Dean D Metcalfe; Hong Yi; Adriana C Cardona; Michael K Lindsay; Aftab A Ansari
Journal:  Blood       Date:  2007-03-09       Impact factor: 22.113

6.  HIV-1 co-receptor expression on trophoblastic cells from early placentas and permissivity to infection by several HIV-1 primary isolates.

Authors:  B Mognetti; M Moussa; J Croitoru; E Menu; D Dormont; P Roques; G Chaouat
Journal:  Clin Exp Immunol       Date:  2000-03       Impact factor: 4.330

7.  The low viral production in trophoblastic cells is due to a high endocytic internalization of the human immunodeficiency virus type 1 and can be overcome by the pro-inflammatory cytokines tumor necrosis factor-alpha and interleukin-1.

Authors:  Gaël Vidricaire; Mélanie R Tardif; Michel J Tremblay
Journal:  J Biol Chem       Date:  2003-02-25       Impact factor: 5.157

8.  Male DNA in female donor apheresis and CD34-enriched products.

Authors:  Kristina M Adams; Nathalie C Lambert; Shelly Heimfeld; Tracy S Tylee; Jennifer M Pang; Timothy D Erickson; J Lee Nelson
Journal:  Blood       Date:  2003-07-17       Impact factor: 22.113

9.  Two-dose intrapartum/newborn nevirapine and standard antiretroviral therapy to reduce perinatal HIV transmission: a randomized trial.

Authors:  Alejandro Dorenbaum; Coleen K Cunningham; Richard D Gelber; Mary Culnane; Lynne Mofenson; Paula Britto; Claire Rekacewicz; Marie-Louise Newell; Jean Francois Delfraissy; Bethann Cunningham-Schrader; Mark Mirochnick; John L Sullivan
Journal:  JAMA       Date:  2002-07-10       Impact factor: 56.272

Review 10.  Mother-to-child transmission of HIV infection and its prevention.

Authors:  Claire Thorne; Marie-Louise Newell
Journal:  Curr HIV Res       Date:  2003-10       Impact factor: 1.581

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.